Capital Com MENA Securities Trading LLC is regulated by the Capital Market Authority.
Open platformOpen platform

Enanta Pharmaceuticals CEO Jay Luly Announces Retirement by February 1, 2027

By Public Technologies
  • Enanta Pharmaceuticals President and CEO Jay R. Luly, 70, will retire by February 1, 2027, following 23 years of leadership.
  • Luly will serve as a strategic advisor for the remainder of 2027 to support the transition.
  • The board has launched a search for his successor, considering internal and external candidates.
  • Tara L. Kieffer, most recently chief product strategy officer, was appointed to the newly created chief operating officer role.
  • Kieffer joined Enanta in 2020 following a 16-year career at Vertex Pharmaceuticals spanning research, clinical development and business functions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enanta Pharmaceuticals Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261028569198) on October 28, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.